Ozempic Users Are Ditching Dining Out—Is the Restaurant Industry at Risk?

As the popularity of Ozempic and other GLP-1 drugs skyrockets, restaurants could be facing a new kind of appetite suppressant. According to a Bloomberg Intelligence report, over half of GLP-1 users say they’re dining out and ordering takeout less often—opting instead for home-cooked meals and grocery store runs. With some food companies already adjusting products to match the shifting habits of these users, the hospitality industry may need to brace for yet another disruption. From economic headwinds to evolving waistline-conscious consumer behavior, the question isn’t just what’s for dinner—it’s where people are choosing to eat it.